Wednesday 14 October 2026
Export ALHC’s income statement to Excel — free account
Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
8.30
0.21
+2.60%
Follow ALHC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
113.38 | 160.18 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.08 | 0.85 | 0.99 | 0.95 | |
P/FCF ratio |
27.83 | 16.00 | 34.54 | 23.06 | |
P/Operating CF |
(285.28) | 28.12 | (77.63) | 24.03 | |
P/B ratio |
18.63 | 17.49 | 21.81 | 21.46 | |
Price to Tangible BV |
21.61 | 21.25 | 27.41 | 27.73 | |
EV/Sales |
1.00 | 0.76 | 0.92 | 0.87 | |
EV/EBITDA |
52.06 | 48.01 | 79.46 | 98.40 | |
EV/Operating CF |
22.20 | 12.77 | 25.95 | 17.36 | |
EV/FCF |
25.71 | 14.22 | 32.07 | 20.93 | |
Quick Ratio |
1.46 | 1.39 | 1.54 | 1.41 | |
Current Ratio |
1.70 | 1.58 | 1.71 | 1.61 | |
Net Debt/EBITDA |
(7.48) | (17.04) | 123.97 | (20.34) | |
Debt/Assets |
25.34% | 25.65% | 30.32% | 29.27% | |
Debt/Equity |
1.22 | 1.56 | 1.80 | 1.99 | |
Asset Turnover |
4.02 | 3.95 | 4.27 | 4.05 | |
Operating CF/Net income |
(0.47) | 11.27 | 4.58 | 38.77 | |
Capex/Depreciation |
(1.21) | (0.91) | (0.63) | (0.68) | |
Interest Coverage |
9.85 | 3.82 | (2.60) | 1.94 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.81% | 9.81% | 12.42% | 11.07% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
1.36% | 1.13% | 1.29% | 1.63% | |
Graham Net Nets |
0.03 | 0.03 | 0.02 | 0.01 | |
Graham Number |
2.46 | 1.58 | 0.00 | 0.00 | |
Earnings Yield |
0.88% | 0.62% | 0.00% | (0.63%) | |
Free Cash Flow Yield |
3.59% | 6.25% | 2.90% | 4.34% | |
Revenue per Share |
6.44 | 6.01 | 5.12 | 4.99 | |
Operating CF per Share |
(0.08) | 0.63 | (0.25) | 0.73 | |
Capex per Share |
(0.05) | (0.04) | (0.03) | (0.03) | |
Free Cash Flow per Share |
(0.13) | 0.59 | (0.28) | 0.70 | |
Cash per Share |
3.38 | 3.54 | 3.05 | 3.24 | |
Shareholders Equity per Share |
1.28 | 1.01 | 0.91 | 0.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.28 | 1.01 | 0.91 | 0.81 | |
Free Cash Flow |
(27.46) | 121.32 | (55.40) | 139.06 | |
Working Capital |
477.04 | 420.61 | 394.71 | 374.24 | |
Capital Expenditures |
(10.14) | (7.36) | (5.03) | (5.50) | |
Net Current Asset Value |
146.54 | 90.64 | 65.07 | 44.58 | |
EV/EBIT |
82.97 | 90.25 | 246.15 | 1,265.92 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
89.81 | 101.50 | 265.09 | 1,394.23 | |
| Other line items | |||||
Average Receivables |
289.91 | 245.87 | 203.56 | 179.34 | |
Average Payables |
565.76 | 557.62 | 409.88 | 442.66 | |
Average Assets |
1,139.59 | 1,078.61 | 923.92 | 897.45 | |
Average Common Equity |
203.05 | 157.94 | 140.12 | 138.75 |
Columns are period end dates